Treatment of Periodontal Disease During
Pregnancy
A Randomized Controlled Trial
John P. Newnham, FRANZCOG, Ian A. Newnham, FRACDS(Perio), Colleen M. Ball, RN,
Michelle Wright, AssocDDentHyg, Craig E. Pennell, FRANZCOG, Jonathan Swain, MDSc(Perio),
and Dorota A. Doherty, PhD
OBJECTIVE: Toinvestigatewhethertreatingperiodontal risk (n(cid:1)3,737) were examined for periodontal disease.
disease prevents preterm birth and other major compli- Approximately 1,000 women with periodontal disease
cationsofpregnancy. were allocated at random to receive periodontal treat-
mentcommencingaround20weeksofgestation(n(cid:1)542)
METHODS: This single-center trial was conducted
or6weeksafterthepregnancywascompleted(controls;
across six obstetric sites in metropolitan Perth, Western
n(cid:1)540). The treatment included mechanical removal of
Australia.Pregnantwomenidentifiedbyhistorytobeat
oral biofilms together with oral hygiene instruction and
motivation at a minimum of three weekly visits, with
furthervisitsifrequired.
From the Schools of Women’s and Infants’ Health and Dentistry of The
UniversityofWesternAustralia;theWomenandInfantsResearchFoundation RESULTS: Therewerenodifferencesbetweenthecon-
ofWesternAustralia;andtheOralHealthCentreofWesternAustralia,Perth, trol and treatment groups in preterm birth (9.3% com-
WesternAustralia.
pared with 9.7%, odds ratio [OR] 1.05, 95% confidence
Supported by a 3-year project grant from the National Health and Medical interval [CI 0.7–1.58], P(cid:1).81), birth weight (3,450 com-
ResearchCouncilofAustralia(no.353577),theWomenandInfantsResearch pared with 3,410 g, P(cid:1).12), preeclampsia (4.1% com-
FoundationofWesternAustralia,andChannel7TelethonofWesternAustra-
lia.FundswereprovidedbyColgate-Palmolivetosupplementthesalariesofthe pared with 3.4%, OR 0.82, 95% CI 0.44–1.56, P(cid:1).55), or
dentalhygienists.OralBprovidedoralhealthcareproductsthatweregivento other obstetric endpoints. There were four unexplained
thewomenatthetimeoftreatment. stillbirthsinthecontrolgroupandnopregnancylossesin
The authors thank Dr. Peter Jarman, Head of Dental Services of Western thetreatedgroup(P(cid:1).12).Measuresoffetalandneonatal
Australia,forfacilitatingaccesstoperipheraldentalclinics;thestudyhygienists, well-being were similar in the two groups, including
Esther Jansen, Belinda Orrock, Dagmar Toman, Lynne Patrick, and Rhona abnormalities in fetal heart rate recordings (P(cid:1).26), um-
Brooksbank, and Lorraine Howard, a dental assistant, for screening and
providingperiodontaltreatmentduringthestudy;thestudymidwives,Renate bilical artery flow studies (P(cid:1).96), and umbilical artery
McLaurin,CherryYoung,DoloresGasbarro,DesireeCavil,MelanieMosey,and bloodgasvalues(P(cid:1).37).Theperiodontaltreatmentwas
Sally Bakker, for recruitment and data collection; and Professor John highlysuccessfulinimprovinghealthofthegums(P<.01).
McGeachie,whoassistedwiththestudydesign.Theauthorsalsothankmembers
of the data safety monitoring committee for monitoring the safety of women CONCLUSION: The evidence provided by the present
participating in the study: Prof. Jan Dickinson (Chair), The University of studydoesnotsupportthehypothesisthattreatmentof
Western Australia, and Prof. Caroline Crowther, University of Adelaide, for periodontal disease during pregnancy in this population
monitoringoftheobstetricoutcomes;Prof.PaulAbbott,OralHealthCentreof
prevents preterm birth, fetal growth restriction, or pre-
WesternAustraliaandTheUniversityofWesternAustralia,formonitoringof
eclampsia. Periodontal treatment was not hazardous to
theperiodontaltreatment;andMs.LizNathan,Biostatistician,Womenand
InfantsResearchFoundation,forprovidingindependentbiostatisticaladvice. thewomenortheirpregnancies.
Presentedasanoralpresentationatthe56thAnnualMeetingoftheSocietyfor CLINICALTRIALREGISTRATION: ClinicalTrials.gov,www.
GynecologicInvestigation,March17–21,2009,Glasgow,UnitedKingdom. clinicaltrials.gov,NCT00133926.
Corresponding author: John P. Newnham, FRANZCOG, School of Women’s (ObstetGynecol2009;114:1239–48)
and Infants’ Health, The University of Western Australia, King Edward
LEVELOFEVIDENCE: I
MemorialHospital,374BagotRoad,Subiaco,Perth,WesternAustralia6008;
e-mail:john.newnham@uwa.edu.au.
FinancialDisclosure Despiteseveraldecadesofmajorimprovementsin
Theauthorsdidnotreportanypotentialconflictsofinterest.
diagnosticandtherapeuticsystemsusedinante-
©2009byTheAmericanCollegeofObstetriciansandGynecologists.Published
natal care, the rates of many major complications of
byLippincottWilliams&Wilkins.
ISSN:0029-7844/09 pregnancy are not decreasing, including preterm
VOL.114,NO.6,DECEMBER2009 OBSTETRICS&GYNECOLOGY 1239
birth.1 A vital clue as to the origin of many cases of tiveofperiodontaldisease(unpublishedobservations,
pretermbirthhascomefromthediscoverythatinflam- 2003). Women were eligible for recruitment if they
matorypathwaysmaybeinvolvedinahighproportion were more than 16 years of age; did not have
ofearlydeliveries,suggestingthepresenceofinfection.2 maternalcardiacdiseasethatwouldwarranttheneed
Trialsusingantibioticshaveingeneralfailedtoprevent for antibiotics for periodontal examination or treat-
preterm birth,3 suggesting that if the inflammation is of ment;hadnotalreadyreceivedperiodontaltreatment
bacterialorigin,thesourcemaybeadistantsite,andone during the current pregnancy; had no fewer than 20
thatwillnotrespondtoconventionalantibiotictherapy. naturalteeth;hadasinglepregnancyofmorethan12
Periodontaldiseaseisonepossibility.4 andlessthan20weeksofgestationalage;didnothave
Many case series and cohort studies have shown any known fetal anomalies or other risk factors, such
significant associations between periodontal disease as hydramnios, that would place the pregnancy at
and preterm birth,5 fetal growth restriction,4 and imminent risk of complications; and were able to
preeclampsia.6 Experiments using animals have also attendregularlyforperiodontaltreatmentifrequired.
shownstrongassociationsbetweenperiodontalpatho- Periodontal screening studies were conducted at
gens and fetal death7–9 and growth restriction.7 The King Edward Memorial Hospital, the Oral Health
mechanismsbywhichaninflamedandinfectedperi- CentreofWesternAustralia,OsborneParkHospital,
odontium could adversely affect the pregnant uterus SwanDistrictsHospital,ArmadaleHospital,Rocking-
and developing fetus are uncertain, although evi- hamHospital,andJoondalupHospital.Thelatterfive
dence suggests roles for translocation of periodonto- hospitalsaresecondarylevelcentersacrossmetropol-
pathic organisms, and stimulation and release of itan Perth, whereas King Edward Memorial Hospital
inflammatory mediators and prostaglandins into the is the tertiary-level perinatal center for the state of
maternal circulation.10 Western Australia. Informed written consent to con-
Evidence from seven trials of treatment during duct the screening study was obtained by a research
pregnancy are now available, but many of the find- midwife. These screening studies were performed by
ings are in conflict and inconclusive.11 The largest of one of five research hygienists under the supervision
these trials, the Obstetric and Periodontal Therapy of two specialist periodontists (I.N. and J.S.). The
(OPT) Study, observed no beneficial effect of peri- examinationswereamodifiedCommunityPeriodon-
odontal treatment on preterm birth or birth weight, tal Index of Treatment Needs study conducted in a
but did observe a possible effect of preventing still- well-equippeddentalenvironment.13Eachstudytook
birth, the certainty of which was unclear.12 approximately 20 minutes to conduct. Periodontal
Thepurposeofthepresentstudywastoperform disease was defined as presence of periodontal pockets
a randomized controlled trial of treatment of peri- of4mmorgreaterindepthat12ormoreprobingsites
odontaldiseaseinmidpregnancytoinvestigatewhether infullyeruptedteeth(typicallyexcludingwisdomteeth).
suchtreatmentmaypreventpretermbirth,fetalgrowth Thisdefinitionwasbasedontheresultsofapilotstudy
restriction,andpreeclampsia.Ourstudywasconducted that showed that 15.4% of our general antenatal popu-
byasinglegroupofinvestigatorsoperatingfromamajor lation had periodontal disease of this degree (unpub-
center,withscreeningandtreatmentsatsixadditional lished observations, 2003). Periodontal pocketing was
sites within metropolitan Perth, Western Australia. usedtodefinethepresenceofperiodontaldiseaserather
than loss of clinical attachment because it better repre-
MATERIALS AND METHODS sentsthemicrobialchallengeandisthemostfrequently
The Smile Study was a single-center randomized usedcriterionofcurrentdisease.
controlledtrialoftreatmentforperiodontaldiseasein Pregnant women were invited to participate in
midpregnancy conducted at seven sites in one city. thetreatmentstudyifthefindingsfromthescreening
Theprotocolwasapprovedbytheethicscommittees examination met the criteria for periodontal disease.
responsible for each of the study sites. Pregnant Informed written consent for treatment was obtained
women were invited to participate in public and byaresearchmidwifeorhygienist.Aquestionnairewas
private antenatal clinics and offices across metropol- thenadministeredtoobtaindataondemographic,den-
itan Perth, Western Australia. Advertisements in the tal,andmedicalaspectsofthewoman’shealth.
lay media and promotional material in clinical envi- Randomization was conducted by a research
ronmentsinvitedwomenwhohadconcernsaboutthe midwife or hygienist using computer randomization
healthoftheirgums,painonbiting,bleedingfromthe softwarespecificallydesignedtoallocateeachcaseat
gums,orahistoryofpretermbirth.Wehadobserved random with stratification for nulliparity, history of
inapreviousstudythatthesefouritemswerepredic- pretermbirth,andcurrentsmoking.Womenfoundto
1240 Newnhametal PeriodontalDiseaseinPregnancy OBSTETRICS&GYNECOLOGY
have a periodontal disease were randomly allocated vided at each visit. The advice included recommen-
to receive periodontal treatment in midpregnancy dations for tooth brushing and flossing after every
(treatmentgroup;n(cid:1)542)orafterthepregnancywas mealandrinsingwith0.12%non–alcohol-basedchlo-
concluded (control group; n(cid:1)540). rhexidine mouthwash. Local anesthesia was used as
The women who were found to not have peri- required(1%lignocainewith1:80,000adrenalinupto
odontal disease were provided with a written record amaximumdoseof4.4mLpertreatmentvisit).These
of their examination but were not involved in the treatment sessions were provided on three occasions
study thereafter. at weekly intervals commencing around 20 weeks of
Treatment was preceded by full periodontal ex- gestation. Each woman was given $10 to reimburse
amination, including precise measurement of peri- for travel expenses at each treatment visit.
odontalpocketdepthto0.2mmwithaFloridaprobe Four weeks after the final treatment, typically at
(Florida Probe Corporation, FL). Data obtained by 28 weeks of gestation, a further examination was
this system are recorded directly into a computer conducted to provide a quantified assessment of the
database.14 Examination also included measurement success of treatment. This assessment included a
of clinical attachment loss, bleeding after probing clinical examination and measurements with a Flor-
across the full mouth, and calculation of a modified idaprobe.Thosewomeninwhomthetreatmenthad
O’Leary Plaque Index.15 A treatment plan was then not been successful were offered a further 3-week
devised, often in consultation with a specialist peri- treatmentregimen(107[19.6%]womenwerefoundto
odontist, and discussed with the woman. require additional treatment visits).
The primary objective of the treatment was to All women in the antenatal treatment arm of the
remove or control various biofilms that act as reser- study were examined again at 32 and 36 weeks of
voirs for the bacterial load. Treatments were con- gestation. The success of treatment was again quanti-
ducted either by the hygienists or periodontists and fied, and oral hygiene advice and motivation were
included nonsurgical de´bridement of the subgingival provided. Systemic antibiotics were not provided for
andsupragingivalplaque,removaloflocalpredispos- periodontal disease.
ing factors such as calculus, root planing, and adjust- Womenallocatedtothepostnatal(control)group
ment of overhanging restorations. Comprehensive were offered periodontal care after the birth, com-
oral hygiene instructions and motivation were pro- mencing 6 weeks after delivery. They had no further
Assessed for eligibility
N=6,340
Excluded:n=2,603
Ineligible: 882
Declined:1,721
Screened for
periodontal disease
n=3,737
No significant
periodontal disease
n=2,650
Randomized
n=1,087
Assigned to Assigned to no treatment
antenatal treatment during pregnancy
n=546 n=541
Withdrew consent
prior to treatment
n=5
Attended 1 or more visits: Received no treatment
n=504; 93% during pregnancy
1 visit: 95; 19%* n=540
2 visits: 280; 56%
3 visits: 105; 21%
4 or more visits: 24; 5%
Not analyzed:n=3 Com np =le 4t 7e 6d ; t 8re 8a %tment Not analyzed:n=1 Fig. 1. Enrollment of study patients.
Lost to follow-up: 1 Lost to follow-up: 0 *Percentages do not sum to 100 be-
Pregnancies excluded Triplet pregnancy causeofrounding.
(miscarriages before excluded: 1
treatment): 2 Analyzed Analyzed Newnham. Periodontal Disease in
n=538 n=540 Pregnancy. Obstet Gynecol 2009.
VOL.114,NO.6,DECEMBER2009 Newnhametal PeriodontalDiseaseinPregnancy 1241
contact with any members of the research team until Primary data analysis was performed on the inten-
their pregnancy was concluded. The postnatal care tion-to-treat principle. Secondary subgroup analyses
involved the same 3-week treatment protocol as for of dose response effects to treatment compared preg-
womenintheantenataltreatmentgroup.Afollow-up nancyoutcomesaccordingtothediseaseseverityand
visit was then offered 4 weeks later to assess the treatment compliance during pregnancy (noncompli-
effectiveness of the treatment. ant women in the treatment group were excluded
All medical, nursing, and perinatal pathology from this analysis). Results of this analysis were
staff members were unaware of the treatment alloca- similartothoseobtainedwhenusingtheintention-to-
tionofeachwomaninthestudy,andhealthcarewas treat approach and are not shown. SPSS (SPSS Inc.,
providedaccordingtostandardprotocolswithineach ChicagoIL)statisticalsoftwarewasusedfordataanaly-
clinic and hospital. Details of all medical, obstetric, sis.P(cid:2).05wasconsideredstatisticallysignificant.
andneonataloutcomeswereextractedfromthemed-
ical records by research midwives who were also RESULTS
blinded to the treatment allocation. Twenty-four Atotal6,340womenwereinvitedtoparticipateinthe
women had moved interstate or overseas, and their study between February 2005 and December 2007,
obstetric and neonatal outcomes were obtained by
telephone(nineinthecontroland15intheantenatal Table 1. Characteristics of the Women and Their
Pregnancies at Trial Entry
treatment group, respectively). Stillbirth in Australia
is defined as death of the unborn fetus after 20 Treatment Control
completed weeks of gestation or more than 400 g Group Group
birth weight. (n(cid:1)538) (n(cid:1)540) P
The primary hypothesis was that treatment of
Maternalage(y)* 30.5(5.5) 30.5(5.5) .842
periodontal disease during pregnancy reduces the Race .897
rate of preterm birth from 12% to 7%. A sample size White 394(73.2) 400(74.1)
of1,082womenwasrequiredtodetectthisreduction Asian 88(16.4) 87(16.1)
in the preterm birth rate with 80% ((cid:1)(cid:1).20) power Aboriginal 23(4.3) 22(4.1)
African 23(4.3) 17(3.1)
while using a two-sided test of proportions at 5%
Hispanic 5(0.9) 7(1.3)
significance level ((cid:2)(cid:1).05). Other 5(0.9) 7(1.3)
Weinitiallyplannedastudywithasamplesizeof Highesteducation(y)† .077
1,094 women, which included an interim analysis to Lessthan10 8(1.5) 13(2.4)
11–12 251(46.7) 277(51.3)
be conducted when 60% of the study pregnancies
Morethan12 146(27.1) 113(20.9)
were completed. In August 2007, the independent
Universitydegree 128(23.8) 135(25.0)
datasafetymonitoringcommitteerecommendedpro- Bodymassindex(kg/m2)* 25.0(5.5) 24.9(5.4) .864
ceeding without an interim analysis after data on treat- Smokingduringpregnancy
ment safety and pregnancy outcomes from the trial Atrecruitment 152(28.0) 152(28.0) .941
Duringtreatment 95(17.7) 95(17.7) .831
conductedbyMichalowiczetal12 werepublished.
Alcoholduringpregnancy 78(14.5) 75(13.9) .793
Continuous outcomes were summarized using
Illicitdruguse 14(2.6) 13(2.4) .842
meansandstandarddeviationsormediansandinter- Nulliparous 236(43.9) 233(43.1) .812
quartileranges,asappropriate.Categoricaloutcomes Previouspregnancies
were summarized using frequency distributions. Uni- Previouspretermbirth 40(13.2) 34(11.1) .412
Anyabortions 153(50.7) 143(46.6) .314
variable comparisons of pregnancy outcomes were
Anyspontaneous 102(33.2) 102(33.8) .932
based on the Mann-Whitney or t test for continuous
abortions
data and the (cid:3)2 or Fisher exact test for categorical Anystillbirths 11(3.6) 12(3.9) .863
data.Comparisonoftherateofpretermbirthadjusted Preexistingdiabetes 7(1.3) 14(2.6) .126
for parity, smoking, and history of preterm birth was Preexistinghypertension 8(1.5) 11(2.1) .509
Preeclampsia(current 18(3.4) 22(4.1) .551
performedusinglogisticregressionanalysiswithodds
pregnancy)
ratios (ORs) and their 95% confidence intervals (CIs)
Gestationalhypertension 53(10.1) 59(11.1) .607
used to summarize the treatment effect. Supplemen- (currentpregnancy)
tary univariate comparisons of gestational ages at
Dataaren(%)unlessotherwiseindicated.
delivery between groups were based on Kaplan- Pvaluesforgroupcomparisonsarebasedonttestsforcontinuous
Meier survival curves and the log rank test, and a
dataand(cid:3)2orFisherexacttestsforcategoricaldata.
*Mean(SD).
proportionalhazardsCoxregressionmodelwasused
†Percentage totals less than 100% are due to missing data
foradjustedanalyseswithhazardratiosandtheirCIs. (highesteducation).
1242 Newnhametal PeriodontalDiseaseinPregnancy OBSTETRICS&GYNECOLOGY
withthefinalpregnancyconcludinginJune2008(Fig. foretheirfirstscreeningexamination.Follow-updata
1). The women were approached either directly by were available for all women except one in the
research midwives within a clinical environment, or antenatalgroup,whowasknowntohaveleftAustralia
theyrespondedbytelephonetopromotionalmaterial to give birth in her country of origin.
in the lay press. Of these, 3,737 women were re- The two groups were similar in baseline mater-
cruitedandreceivedascreeningexaminationoftheir nal characteristics (Table 1): 71.6% of the women
periodontal status. These examinations identified were Caucasian, 98.0% had received more than 9
1,087 women (29.1%) with periodontal disease, each years of education, the mean prepregnancy body
of whom then provided consent to participate in the mass index was 24.9 kg/m2, and 45.1% had expe-
treatment arm of the study. Five hundred forty-one rienced a previous spontaneous or induced preg-
women were allocated at random to receive peri- nancy loss. There were no differences between the
odontal treatment commencing 6 weeks after the two groups in rates of preeclampsia (P(cid:1).551, OR
pregnancy was concluded (control group), and 546 0.82, 95% CI 0.44–1.56) or gestational hyperten-
womenwereallocatedatrandomtoreceivetreatment sion (P(cid:1).607, OR 0.88, 95% CI 0.59–1.31).
commencingat21weeksofgestation(treatmentgroup). Four fetuses in the control group were stillborn
Five women assigned to antenatal treatment withdrew (Tables2and3).Allfourwerefrompregnanciesthat
their consent before treatment commenced. One wereuncomplicated,andtheirmotherswereallmar-
woman was excluded when found at 19 weeks of ried, had more than 12 years of education, and were
gestation to have a multiple pregnancy. Two women nonsmokers. In each case, the perinatal pathologist
had spontaneous abortions after recruitment and be- classifiedthecauseofstillbirthasunknown,andthere
Table 2. Birth and Newborn Outcomes
TreatmentGroup ControlGroup
(n(cid:1)538) (n(cid:1)540) P
Pregnancyoutcomes
Stillbirth — 4(0.7) .124
Neonataldeath — 1(0.2) .501
Pretermbirth 52(9.7) 50(9.3) .812
Gestationalageatdelivery(wk)* 39.6(38.4–40.4) 39.6 .548
Onsetoflabor†
Spontaneous 258(48.0) 244(45.2) .436
Induced 132(24.5) 158(29.3)
Augmented 57(10.6) 55(10.2)
Nolabor 79(14.7) 77(14.3)
Modeofdelivery†
Spontaneousvaginal 276(51.3) 280(51.9) .488
Assistedvaginal 88(16.4) 79(14.6)
Electivecesarean 71(13.2) 64(11.9)
Emergencycesarean 93(17.3) 111(20.6)
Fevergreaterthan37(cid:1)Cinlabor‡ 37(7.1) 47(8.9) .283
Primarypostpartumhemorrhage 27(5.2) 37(7.0) .220
(greaterthan1,000mL)‡
Retainedplacenta‡ 12(2.3) 13(2.4) .866
Secondarypostpartumhemorrhage‡ 5(1.0) 7(1.3) .579
Newbornoutcomes
Male 269(50.1) 262(48.5) .605
Birthweight(g)* 3,410(3,057–3,760) 3,450(3,111–3,800) .117
Fractionofexpectedbirthweight* 1.03(0.93–1.10) 1.03(0.95–1.12) .103
Birthweightlessthan10thpercentile 52(9.6) 39(7.2) .152
Headcircumference(cm)* 35(33–36) 35(34–36) .123
Length(cm)* 50(48–52) 50(49–52) .615
Sepsisnecessitatingantibiotics‡ 25(4.7) 17(3.1) .201
Dataaren(%)unlessotherwiseindicated.
PvaluesforgroupcomparisonsarebasedonMann-Whitneytestsforcontinuousdataand(cid:3)2orFisherexacttestsforcategoricaldata.
*Median(interquartilerange).
†Percentagetotalslessthan100%areduetomissingdata(onsetoflabor,modeofdelivery).
‡Percentagecalculationsexcludemissingdata.
VOL.114,NO.6,DECEMBER2009 Newnhametal PeriodontalDiseaseinPregnancy 1243
Table 3. Details of the Pregnancies Resulting in Stillbirth
Gestational Birth Regular Painon AvoidEating BleedingGums No.of Periodontal
Case Age(wk) Weight(g) DentalVisits Biting onSomeTeeth DuringBrushing Teeth Disease*(%)
1 26 770 Asneeded Rarely Rarely Daily 29 11.5
2 27 800 Asneeded Never Never Daily 28 11.9
3 38 2,800 Never Weekly Weekly Daily 30 15.6
4 40 4,350 Annual Notgiven Never Daily 24 36.1
All four pregnancies were uneventful, no abnormalities were found during postmortem examination, and all placentas were described
as unremarkable. Oral health characteristics reported by women at recruitment and assessed during the screening examination are
shown.
*Percentageoftoothsiteswithprobingdepth4mmorgreater.
were no features of inflammation in the fetus or threatenedabortion(P(cid:1).011,OR2.83,95%CI1.26–
placenta.Allfourmothershadgivenhistoriesofdaily 6.34),andantepartumhemorrhage(P(cid:2).001,OR3.75,
occurrencesofbleedingfromtheirgumsduringtooth 95% CI 1.91–7.36). Risk of preterm delivery for
brushing, and on periodontal examination each had nulliparous women was similar to that of parous
bleeding,inflammation,andplaquelevelsclassifiedas women who had no history of preterm delivery
moderate. There was a single neonatal death, occur- (P(cid:1).838, OR 1.05, 95% CI 0.64–1.72).
ringat1hourofageafterpretermbirthat22weeksof The type of onset of labor was similar for each
gestation. The pregnancy had been complicated by group(P(cid:1).436).Birthweightsweresimilarinthetwo
antepartum hemorrhage and was in the control
groups when expressed either as mean birth weight
group. Except for a single case of loss to follow-up (P(cid:1).117)orexpectedbirthweightforgestationalage
where the neonatal outcome was unknown, all re-
using charts derived from the local population
maining538womenallocatedtothetreatmentgroup (P(cid:1).103).
completed their pregnancies and were discharged to
Therewerenodifferencesbetweenthetwogroups
home with a live infant.
in measures of fetal welfare or health of the newborn
The two groups were similar in duration of
(Table 4). These measures included incidence of
pregnancy, either when expressed as the rate of
preterm birth (P(cid:1).812, OR 1.05, 95% CI 0.7–1.58) nonreassuring fetal heart rate traces (P(cid:1).264), the
needfordeliverybasedonabnormalfetalheartrate
or when compared using estimated Kaplan-Meier
patterns (P(cid:1).687), the presence of meconium in
cumulative probabilities of delivery (Figure 2)
(P(cid:1).548, hazard ratio 1.02, 95% CI 0.91–1.15) and amniotic fluid (P(cid:1).522), cesarean delivery for fetal
median gestational age at delivery (Table 2). Fac- distress (P(cid:1).720), Apgar scores less than 7 at 1 or 5
tors simultaneously associated with an increased minutes (P(cid:1).403 and P(cid:1).988, respectively), the need
risk of preterm delivery included historyofpreterm for resuscitation of the newborn (P(cid:1).133), umbilical
delivery (P(cid:1).002, OR 2.71, 95% CI 1.42–5.17), pre- artery pH (P(cid:1).371), PCO2 (P(cid:1).867) and base excess
eclampsia (P(cid:2).001, OR 17.56, 95% CI 8.75–35.24), (P(cid:1).864) values, or the need for admission to the
Fig. 2. Kaplan-Meier curves of the
cumulative incidence of deliveries
accordingtogestationalage.There
were no differences between the
treatmentandcontrolgroups(P(cid:1).55,
hazard ratio 1.02, 95% confidence
interval0.91–1.15).A.Survivalplots
limited to preterm deliveries and
highlightinggroupdifferences.B.All
deliveriescombined.
Newnham. Periodontal Disease in
Pregnancy.ObstetGynecol2009.
1244 Newnhametal PeriodontalDiseaseinPregnancy OBSTETRICS&GYNECOLOGY
Table 4. Tests of Fetal and Neonatal Well-Being
TreatmentGroup ControlGroup
(n(cid:1)538) (n(cid:1)540) P
Fetal
AFImeasured* 285(55.2) 307(58.6) .275
AFIlessthan5cm 6(2.1) 9(2.9) .521
AFImorethan25cm 2(0.7) 6(1.9) .288
UmbilicalarteryS/Dratiosmeasured* 186(35.6) 190(35.8) .941
AbnormalS/Dratios 8(4.3) 8(4.2) .965
ElectronicFHRmonitoringinlabor* 308(59.3) 317(60.2) .790
Nonreassuring 115(37.3) 102(32.2) .175
Decisionondeliverybasedon
electronicFHRmonitoring*
No 42(37.2) 32(32.0) .687
Partially 25(22.1) 22(22.0)
Yes 46(40.7) 46(46.0)
ScalppHmeasuredinlabor* 14(2.7) 17(3.2) .614
Meconiuminamnioticfluid* 76(14.6) 85(16.0) .522
Nonreassuringfetalheartratepattern 61(13.3) 64(13.6) .894
inlabor*†
Cesareandeliveryfornonreassuring 35(7.7) 39(8.3) .720
fetalheartratepattern*†
Neonatal
Apgarscorelessthan7
1min* 61(11.7) 53(10.1) .403
5min* 8(1.5) 8(1.5) .988
Resuscitation*
None 309(59.1) 354(66.7) .133
Suction 76(14.5) 61(11.5)
Oxygen 74(14.1) 67(12.6)
Bagandmask 56(10.7) 42(7.9)
Intubation 8(1.5) 7(1.3)
Umbilicalarterycordblood
n 279 292
pH‡ 7.27(7.22–7.31) 7.28(7.22to7.32) .371
PCO2‡ 53.9(47.0to60.1) 53.0(47.3to60.6) .867
PO2‡ 18.0(13.2to22.0) 17.1(16.2to22.0) .390
Baseexcess‡ (cid:3)2.6((cid:3)4.6to0.4) (cid:3)2.4((cid:3)4.5to0.4) .864
Ventilation* 6(1.1) 4(0.8) .544
CPAP* 14(2.7) 11(2.1) .518
Oxygen* 12(2.3) 10(1.9) .641
SCNadmission* 66(12.6) 51(9.6) .119
AFI, amniotic fluid index; S/D, systolic/diastolic ratio; FHR, fetal heart rate; CPAP, continuous positive airway pressure; SCN, special
carenursery.
Dataaren(%)unlessotherwiseindicated.PvaluesforgroupcomparisonsarebasedonMann-Whitneytestsforcontinuousdataand(cid:3)2
orFisherexacttestsforcategoricaldata.
*Percentagecalculationsexcludemissingdata.
†Excludingelectivecesareandelivery.
‡Median(interquartilerange).
special care nursery (P(cid:1).119, OR 1.36, 95% CI Four hundred seventy-six women (88.3%) in the
0.92–2.01). treatment group completed their treatment (Fig. 1).
The mean gestational age at the time of the
Among the 63 women who did not complete their
periodontal screening examination was 18.2 weeks
treatment, 35 did not attend any of their scheduled
(Table5).Therewerenodifferencesbetweenthetwo
visits.Thesuccessoftreatmentwasmeasuredaround
groups at recruitment in measures of inflammation
(P(cid:1).459), plaques (P(cid:1).506), bleeding on probing 28weeksofgestation(Table6).Thereweresignificant
(P(cid:1).361), and percentage of tooth sites with probing improvements in all clinical measures of disease afte
depth of 4 mm or greater (P(cid:1).788). treatment.
VOL.114,NO.6,DECEMBER2009 Newnhametal PeriodontalDiseaseinPregnancy 1245
Table 5. Periodontal Characteristics at the Table 6. Responses to Periodontal Treatment
Screening Examination
Treatment First After
Treatment Control Group Treatment Treatment
Group Group (n(cid:1)538) (n(cid:1)504) (n(cid:1)354) P
(n(cid:1)538) (n(cid:1)540) P
Gestationalage 21(20–21) 28(28–28)
Gestationalageat 18.1(2.3) 18.2(2.2) .451 atvisit(wk) (cid:4)Range14–25(cid:5) (cid:4)Range26–29(cid:5)
screening(wk)* %ofsiteswith 13.8(7.6–21.4) 3.3(1.2–7.0) (cid:2).001
Numberofnatural 28.8(2.3) 28.7(2.3) .293 depth4mm
teeth* orgreater
Inflammation† .459 %ofsiteswith 2.4(0.7–5.6) 0.6(0–1.6) (cid:2).001
Minimal 8(1.5) 3(0.6) depth5mm
Mild 106(19.7) 102(18.9) orgreater
Moderate 274(50.9) 291(53.9) %ofsiteswith 1.6(0.5–3.9) 0(0–1.1) (cid:2).001
Heavy 108(20.0) 110(20.4) depth6mm
Severe 36(6.7) 29(5.4) orgreater
Plaque† .506 %sitesbleeding 70.2(54.3–84.0) 28.7(17.9–42.5) (cid:2).001
Minimal 9(1.7) 5(0.9) onprobing
Mild 150(27.8) 173(32.0)
Dataaremedian(interquartilerange).
Moderate 251(46.6) 237(43.9)
Heavy 104(19.3) 101(18.7)
Severe 18(3.3) 20(3.7)
Bleedingon .361 of the hypothesis, with both trials providing strong
probing† evidence that treatment of periodontal disease is
Minimal 12(2.2) 5(0.9)
ineffective in preventing early birth. There are many
Mild 120(22.3) 111(20.6)
differences, however, between many of the random-
Moderate 266(49.4) 274(50.7)
Heavy 116(21.5) 122(22.6) ized controlled trials that have been reported.11 Only
Severe 18(3.3) 24(4.4) three of the seven trials reported adequate random-
%oftoothsites 14.8(10.4–22.5) 14.9(10.7–22.1) .788
izationprocedures,andonlythreetrialswereblinded.
withprobing
Within these various trials was a diversity of patient
depth4mm
orgreater‡ populations.
The first reported trial involved women of Span-
Dataaren(%)unlessotherwiseindicated.
*Mean(standarddeviation). ish and local aboriginal descent who were of low
†Percentage totals less than 100% due to missing data socioeconomic status.17 Preterm birth was less fre-
(inflammation,plaque,bleedingonprobing).
quent in those who had been allocated to receive
‡Median(interquartilerange).
periodontal therapy (1.1% in the treatment group,
6.4% in the control group, P(cid:1).02). The second trial
DISCUSSION was a pilot study, conducted at the University of
The purpose of this study was to investigate whether Alabama in Birmingham.18 Three hundred sixty-six
treatment of periodontal disease during midpreg- women were randomly assigned to scaling and root
nancy prevents complications of pregnancy. Peri- planing, with or without metronidazole, or dental
odontal treatment did not prevent, or cause, preterm prophylaxis and placebo. Eighty-five percent of
birth, fetal growth restriction, or preeclampsia. All women in this trial were African-American. The trial
othermeasuresofpregnancyoutcomeweresimilarin providedsomepreliminaryevidencethatperiodontal
the two groups, with the possible exception of peri- treatment may prevent preterm birth, and that ad-
natal death. There were four stillbirths and one neo- junctive treatment with metronidazole is not of ben-
natal death in the control group and no pregnancy efit and may be harmful. The largest trial reported
losses in the treatment group. until now was the OPT Study conducted in the
Meta-analysisofthefirstseventrialsofperiodon- United States and reported in 2006, which observed
tal treatment during pregnancy revealed a possible preterm birth in 12% of women in the treatment
reductioninpretermbirthandincidenceoflowbirth group and 12.8% in the control group, a difference
weight.11 These findings from randomized trials that was not statistically significant.12
added to observations from observational studies4,16 Thefindinginthepresentstudyoffourstillbirths
indicating associations between periodontal disease inthecontrolgroupandnoneinthetreatmentgroup
and preterm birth. The results of the present study would not in itself be grounds to expect that the
andthoseofthenextlargesttrial12arenotsupportive treatment was protective for the fetus because the
1246 Newnhametal PeriodontalDiseaseinPregnancy OBSTETRICS&GYNECOLOGY
numbers were relatively small, the difference did not preeclampsia. A possible beneficial effect in prevent-
achieve statistical significance, and this was not a ing a proportion of stillbirths remains uncertain.
primary endpoint of the study. There is, however, Several other randomized controlled trials are cur-
evidence from other sources suggesting that such a rentlyinprogress,andmeta-analysesoftheresultsof
protective effect may be real. First, the finding is all studies can be expected to provide conclusive
consistent with that observed in the next largest evidence in the future. Studies also need to be
randomized controlled trial of periodontal treatment performedtoinvestigateanypossiblebenefitsfrom
during pregnancy, the OPT Study, reported by periodontal treatment before conception. In the
Michalowicz et al.12 In that trial, 3 of 407 patients in meantime, the information available to us at this
the treatment group and 10 of 405 patients in the time suggests that periodontal treatment during
control group had a stillbirth. The authors viewed pregnancy is safe for the woman and her preg-
this finding with particular caution because the nancy, and that any beneficial effects for the child
numbers were relatively small. If the numbers of are either nonexistent or likely to be restricted to
stillbirths in the study by Michalowicz et al and the
certainpopulationsorsubgroupsthathaveyettobe
present study are combined by meta-analysis, the
defined with certainty.
reduction in stillbirth after periodontal treatment is
statistically significant (P(cid:1).02, OR 4.00, 95% CI
REFERENCES
1.22–13.10). These two randomized controlled tri-
1. GoldenbergRL,CulhaneJF,IamsJD,RomeroR.Epidemiol-
alshavebeenchosenforthismeta-analysisbecause
ogyandcausesofpretermbirth.Lancet2008;371:75–84.
they are the only ones that share similar study
2. GoldenbergRL,HauthJC,AndrewsWW.Intrauterineinfec-
designs.
tionandpretermdelivery.NEnglJMed2000;342:1500–7.
Second, we have observed previously that women
3. GoldenbergRL,CulhaneJF.Infectionasacauseofpreterm
withahistoryofrecentperinatallossaremorelikelyto birth.ClinPerinatol2003;30:677–700.
haveperiodontaldisease.Inacase–controlstudyof53 4. Xiong X, Buekens P, Fraser WD, Beck J, Offenbacher S.
women whose pregnancy had resulted in perinatal Periodontal disease and adverse pregnancy outcomes: a sys-
tematicreview.BJOG2006;113:135–43.
death compared with 111 matched controls, those
women who had experienced a perinatal loss were 5. OffenbacherS,KatzV,FertikG,CollinsJ,BoydD,Maynor
G, et al. Periodontal infection as a possible risk factor for
more likely to have periodontal disease (OR 2.34,
preterm low birth weight. J Periodontol 1996;67 suppl:
95% CI 1.05–5.47).19 1103–13.
Third, the lethal effects of periodontal pathogens 6. Boggess KA, Lieff S, Murtha AP, Moss K, Beck J, Offen-
in causing fetal death are well established in animal bacherS.Maternalperiodontaldiseaseisassociatedwithan
increased risk for preeclampsia. Obstet Gynecol 2003;101:
models, including both hamsters7,8 and sheep.9
227–31.
Stillbirth,however,wasnotaprimaryendpointof
7. Collins JG, Windley HW III, Arnold RR, Offenbacher S.
the present study. Despite our previous observations EffectsofaPorphyromonasgingivalisinfectiononinflamma-
thatperiodontaldiseasemayincreasetheriskoffetal torymediatorresponseandpregnancyoutcomeinhamsters.
InfectImmun1994;62:4356–61.
death, we were unable to design our study with
8. CollinsJG,SmithMA,ArnoldRR,OffenbacherS.Effectsof
stillbirth as a primary outcome. To perform such a
Escherichia coli and Porphyromonas gingivalis lipopolysac-
study would require a sample size that is unachiev- charideonpregnancyoutcomeinthegoldenhamster.Infect
able within the range of contemporary research Immun1994;62:4652–5.
funding and opportunity. Hence, the value of com- 9. NewnhamJP,ShubA,JobeAH,BirdPS,IkegamiM,NitsosI,et
al. The effects of intra-amniotic injection of periodontopathic
biningresultsfromsimilarstudiesbecomesevident.
lipopolysaccharides in sheep. Am J Obstet Gynecol 2005;193:
The OPTStudyhaddesignfeaturesgenerallysimilar 313–21.
to those of the present study,12 suggesting that results 10. Offenbacher S, Jared HL, O’Reilly PG, Wells SR, Salvi GE,
from the two trials can be combined with relative Lawrence HP, et al. Potential pathogenic mechanisms of
periodontitis associated pregnancy complications. Ann Peri-
confidence. Meta-analysis of the first seven pub-
odontol1998;3:233–50.
lished randomized controlled trials of periodontal
11. Polyzos NP, Polyzos IP, Mauri D, Tzioras S, Tsappi M,
treatment during pregnancy, however, did not pro-
Cortinovis I, et al. Effect of periodontal disease treatment
videreassurancethatstillbirthmaybepreventedby duringpregnancyonpretermbirthincidence:ametaanalysis
such treatment.11 ofrandomizedtrials.AmJObstetGynecol2009;200:225–32.
In conclusion, the evidence provided by the 12. MichalowiczBS,HodgesJS,DiAngelisAJ,LupoVR,NovakMJ,
FergusonJE,etal;OPTStudy.Treatmentofperiodontaldisease
present study does not support the hypothesis that
andtheriskofpretermbirth.NEnglJMed2006;355:1885–94.
treatment of periodontal disease in midpregnancy
13. Cutress TW, Ainamo J, Sardo-Infirri J. The community
prevents preterm birth, fetal growth restriction, or periodontal index of treatment needs (CPITN) procedure
VOL.114,NO.6,DECEMBER2009 Newnhametal PeriodontalDiseaseinPregnancy 1247
for population groups and individuals. Int Dent J 1987;37: 17. Lo´pez NJ, Smith PC, Gutierrez J. Periodontal therapy may
222–33. reduce the risk of preterm low birth weight in women with
14. Gibbs CH, Hirschfeld JW, Lee JG, Low SB, Magnusson I, periodontaldisease:arandomizedcontrolledtrial.JPeriodon-
Thousand RR, et al. Description and clinical evaluation of a tol2002;73:911–24.
newcomputerizedperiodontalprobe:theFloridaprobe.JClin 18. Jeffcoat MK, Hauth JC, Geurs NC, Reddy MS, Cliver SP,
Periodontol1988;15:137–44. Hodgkins PM, et al. Periodontal disease and preterm birth:
15. O’LearyTJ,DrakeRB,NaylorJE.Theplaquecontrolrecord. results of a pilot intervention study. J Periodontol 2003;74:
JPeriodontol1972;43:38. 1214–8.
16. VergnesJN,SixouM.Pretermlowbirthweightandmaternal 19. Shub A, Wong C, Jennings B, Swain JR, Newnham JP.
periodontal status: a meta-analysis. Am J Obstet Gynecol Maternalperiodontaldiseaseandperinatalmortality.AustNZ
2007;196:135.e1–7. JObstetGynaecol2009;49:130–6.
1248 Newnhametal PeriodontalDiseaseinPregnancy OBSTETRICS&GYNECOLOGY
